This 5-hour Zoom webinar is dedicated to cutting-edge innovations in vestibular schwannoma. Join us for a discussion of high-yield technical topics from international thought leaders. Registration is free and open to clinicians, scientists, patients, and patient advocates.

Program Schedule

Welcome and Introduction: Dr. Matthew Carlson and Dr. Michael Link (Mayo Clinic, USA)

Hour 1: Advances in Neuromonitoring

• Continuous facial nerve and cochlear nerve action potential monitoring

• Transcranial motor evoked potentials (MEP) for facial nerve monitoring

• Tailoring extent of resection in vestibular schwannoma microsurgery

• Electrical monitoring of the cochlear nerve for optimizing cochlear implantation

• Discussion / Q&A

Hour 2: Techniques in Vestibular Schwannoma Treatment

• Technical pearls for facial nerve microdissection

• Technical pearls for hearing preservation microsurgery by Dr. Marlan Hansen (University of Iowa, USA)

• Technical pearls of radiosurgery to optimize hearing outcomes by Dr. Douglas Kondziolka (New York University Langone Health System, USA)

• Managing giant tumors by Dr. David Haynes (Vanderbilt University Medical Center, USA)

• Discussion / Q&A

Hour 3: Optimizing Patient Outcomes through Multidisciplinary Care

• Timing and management of facial paralysis after vestibular schwannoma surgery by Dr. Jacob Dey (Mayo Clinic, USA)

• Cochlear implant placement after vestibular schwannoma treatment by Dr. Neil Patel (University of Utah, USA)

• Benefits and organization of a multidisciplinary NF2 clinic by Dr. Matthew Carlson and Dr. Ugur Sener (Mayo Clinic, USA)

• Magnetic resonance imaging after cochlear implantation or auditory brainstem implantation

• Discussion / Q&A

Hour 4: On the Horizon - Molecular Genomics and Applications

• Emerging medical therapies for sporadic and NF2 vestibular schwannoma by Dr. Konstantina Stankovic (Stanford Medicine, USA)

• Prediction of tumor behavior based on genetic profile

• Tumor microenvironment and implications for vestibular schwannoma care by Dr. Omar Pathmanaban (Manchester Centre for Clinical Neurosciences, United Kingdom)

• Circulating-free DNA (cfDNA) and potential applications for CNS tumors

• Discussion / Q&A

Hour 5: Difficult Cases

• Case 1 by Dr. Michel Kalamarides (Sorbonne University, France)

• Case 2

• Case 3

• Case 4

• Discussion / Q&A